Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study

Sponsor
Boston University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05006729
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
4,600
1
49.5
93

Study Details

Study Description

Brief Summary

The Boston University Medical Campus (BUMC) will serve as the site for the RURAL Study Coordinating Center, led by PI Vasan Ramachandran, MD, and the Pulmonary Core, led by George O'Connor, MD.

The primary function of the Study Coordinating Center (SCC) is to serve as an administrative liaison between all of the RURAL study's cores. The SCC schedules, facilitates, and hosts, all RURAL meetings including preparation for Observational Study Monitoring Board (OSMB) meetings, and maintains direct communication with the study's program officers at NHLBI. The SCC monitors the overall progress of RURAL and keeps all RURAL cores abreast of study updates through meetings, emails, newsletters. It also maintains the official RURAL website and serves as an administrator for investigators seeking to collaborate with RURAL through the submission of Ancillary Studies. The SCC will have no direct interaction with any participants, nor will it have access to identifiable data.

The RURAL pulmonary core's primary function will be to read the daily Pulmonary Function Tests (PFTs) performed by participants at each of RURAL's recruiting sites (Alabama, Kentucky, Louisiana, Mississippi). The BUMC Pulmonary Core investigators will receive de-identified data on a daily basis sent by the Statistical Data Coordinating Center at the University of Pennsylvania and will provide a clinical interpretation for each test and "score" the results for quality assurance purposes. Although the Pulmonary Core investigators will not have direct interaction with any participants, in rare circumstances, there may be a need to review identifiable results in the case of a medical emergency at one of the recruiting sites. The pulmonary core will also provide training for all staff who will carry out PFTs.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The Risk Underlying Rural Areas Longitudinal (RURAL) Cohort is a health research project that plans to enroll approximately 4,600 adults in ten rural counties throughout Alabama (AL), Kentucky (KY), Louisiana (LA), and Mississippi (MS). The ten specific counties are: Dallas County, AL; Wilcox County, AL; Boyle County, KY; Perry County, KY; Garrard County, KY; Breathitt County, KY; Assumption Parish, LA; Franklin Parish, LA; Oktibbeha County, MS; and Panola County, MS. The study will help to better understand health and disease in these rural areas. The information gathered in this study will help build future health programs to improve the health of local people in your community, which may promote healthier lives. Several different aspects of the participants' health will be examined including heart and lung function.

    Broad goals of the RURAL Cohort Study include:
    • Identifying the frequency of and risk factors for heart and lung diseases in the RURAL communities

    • Identifying unique factors contributing to health disorders in these communities - including psychosocial, economic, and familial factors - and how they interact together

    • Identifying potential solutions by examining differences between higher and lower risk rural counties

    Findings from the RURAL study will inform health care providers, participants, researchers and the community regarding the frequency, burden, determinants, and prognosis of heart, lung, blood, and sleep diseases in the rural South, provide new knowledge that is critical for rural implementation science, and set the stage for collaborative opportunities for a wider community of scientists.

    Participants in the RURAL Study will receive information on different areas of their health, including their heart and lungs.

    Investigators will visit participants in their communities to complete a research exam about heart and lung health. Participants will attend an in-person exam at the RURAL study mobile exam vehicle. On the mobile exam unit participants will also receive a Fitbit [activity tracker] device and a RURAL cell phone app that will be used to collect information about their health and lifestyle.

    Participants will receive results from their research exam, which they can also share with their doctor. The RURAL Study team will refer participants to a health center if there are immediate health concerns found during the research exam.

    The RURAL Study follows all HIPAA rules and regulations, in addition to the NIH and institutional guidelines, for the protection of all research participants. No information from the study that could identify a participant will be publicly shared.

    The RURAL study team will track participants' physical activity using the provided Fitbit device. The RURAL health team will also ask questions about overall health and lifestyle through the RURAL cell phone app. Participants will receive a kit to measure environmental and health factors in your home.

    The visit in the mobile exam vehicle will take about 3 hours and will include:
    • Vital signs including height and weight

    • Blood draw

    • Interviews and surveys asking about lifestyle and health history

    • Tests related to heart, lung, and blood vessel health

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    4600 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    RURAL Study Coordinating Center and Pulmonary Core
    Actual Study Start Date :
    Jan 15, 2021
    Anticipated Primary Completion Date :
    Mar 1, 2025
    Anticipated Study Completion Date :
    Mar 1, 2025

    Arms and Interventions

    Arm Intervention/Treatment
    RURAL cohort study

    A longitudinal research project in ten rural counties in Alabama, Kentucky, Louisiana, and Mississippi enrolling approximately 4,600 participants from these communities, examining several different aspects of their health, including heart and lung function.

    Outcome Measures

    Primary Outcome Measures

    1. Risk factors for lung disease in rural areas [5 years]

    2. Risk factors for heart disease in rural areas [5 years]

    Secondary Outcome Measures

    1. Pulmonary function [5 years]

    2. Heart function [5 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 64 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Be a resident of specific counties in Alabama, Kentucky, Louisiana, and Mississippi

    • Have resided in the specific county for the past two years and plan to reside at the residence for the next two years

    • Speak English or Spanish

    Exclusion Criteria:
    • Currently incarcerated or institutionalized

    • Currently in hospice care with a terminal illness and less than 6 month life expectancy

    • Being actively treated for cancer

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama Birmingham Alabama United States 35294

    Sponsors and Collaborators

    • Boston University
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Study Director: Vasan Ramachandran, MD, School of Medicine - Preventive Medicine & Epidemiology
    • Principal Investigator: Suzanne Judd, PhD, University of Alabama at Birmingham
    • Principal Investigator: Paul Targonski, MD PhD, University of Virginia

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Boston University
    ClinicalTrials.gov Identifier:
    NCT05006729
    Other Study ID Numbers:
    • H-39102
    • U01HL146382
    First Posted:
    Aug 16, 2021
    Last Update Posted:
    Aug 2, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Boston University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 2, 2022